Glimitab MP 2 mg/500 mg/15 mg Tablet
Marketer
Centaur Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimitab MP 2 mg/500 mg/15 mg Tablet
Combiplus DM 2 mg/500 mg/15 mg tablets effectively manage blood glucose in adults with type 2 diabetes. This triple-combination medication, used alongside diet and exercise, enhances insulin efficiency and reduces blood sugar. Always follow your physician's prescribed dosage and regimen; take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Baseline kidney function tests are typically performed before treatment initiation. Limit alcohol consumption as it may exacerbate side effects.
Primary Ingredients of Glimitab MP 2 mg/500 mg/15 mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glimitab MP 2 mg/500 mg/15 mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimitab MP 2 mg/500 mg/15 mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimitab MP 2 mg/500 mg/15 mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimitab MP 2 mg/500 mg/15 mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimitab MP 2 mg/500 mg/15 mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimitab MP 2 mg/500 mg/15 mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
How Glimitab MP 2 mg/500 mg/15 mg Tablet works:
Glimitab MP 2 mg/500 mg/15 mg tablets contain a triple combination of glimepiride, metformin, and pioglitazone to enhance blood sugar management. This formulation employs diverse mechanisms of action, offering superior glycemic control when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimitab MP 2 mg/500 mg/15 mg Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitab MP 2 mg/500 mg/15 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimitab MP 2 mg/500 mg/15 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimitab MP 2 mg/500 mg/15 mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimitab MP 2 mg/500 mg/15 mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Glimitab MP 2 mg/500 mg/15 mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimitab MP 2 mg/500 mg/15 mg Tablet :
Should you forget to take your Glimitab MP 2 mg/500 mg/15 mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimitab MP 2 mg/500 mg/15 mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently